Keywords: schering, topical, pdt, therapy, gets, approval, aks
Schering's topical PDT therapy gets US approval for AKs
Article | 28 September 2000
Schering AG's photodynamic therapy illuminator, BLU-U, has beenapproved by the US Food and Drug Administration. This blue-light source is used ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
